Beck Bode’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$24.3M Sell
109,341
-3,336
-3% -$776K 3.8% 7
2026
Q2
$26.8M Buy
112,677
+3,656
+3% +$760K 4.05% 3
2026
Q1
$23M Sell
109,021
-6,112
-5% -$1.32M 3.9% 3
2025
Q4
$23.7M Sell
115,133
-10,056
-8% -$1.89M 3.94% 2
2025
Q3
$19.6M Buy
125,189
+974
+0.8% +$150K 3.17% 12
2025
Q2
$20.9M Sell
124,215
-1,061
-0.8% -$157K 3.53% 5
2025
Q1
$17.3M Buy
+125,276
New +$16M 3.22% 9
2020
Q4
– Sell
-2,323
Closed -$109K – 45
2020
Q3
$109K Buy
+2,323
New +$119K 0.04% 75

Other funds holding CAH

Beck Bode's CAH Position: Q3 2026 in Review

Beck Bode reduced its Cardinal Health (CAH) stake by 3% in Q3 2026, selling an estimated $776K and leaving 109,341 shares worth $24.3M. The position accounts for 3.8% of the portfolio, ranked #7.

Beck Bode first reported a position in CAH in Q3 2020 and has held it in 8 quarters since. The position peaked at $26.8M in Q2 2026. 1,272 funds tracked by Wall St. Rank hold CAH as of Q3 2026.

  • Beck Bode held 109,341 shares of Cardinal Health worth $24.3M as of Q3 2026.
  • Beck Bode sold 3,336 Cardinal Health shares in Q3 2026, an estimated $776K.
  • Cardinal Health made up 3.8% of Beck Bode's portfolio in Q3 2026, its #7 holding.
  • Beck Bode first reported a position in Cardinal Health in Q3 2020 and has held it in 8 quarters since.
  • Beck Bode's Cardinal Health position peaked at $26.8M in Q2 2026.
  • 1,272 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2026.

Based on Beck Bode's 13F filing for Q3 2026, filed 12 Nov 2026.